{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:21:28Z","timestamp":1777890088078,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,25]],"date-time":"2021-05-25T00:00:00Z","timestamp":1621900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.oret.2021.05.009","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T03:42:21Z","timestamp":1621395741000},"page":"954-961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan"],"prefix":"10.1016","volume":"5","author":[{"given":"Gregg T.","family":"Kokame","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jase N.","family":"Omizo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli A.","family":"Kokame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya L.","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2021.05.009_bib1","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.oret.2019.04.018","article-title":"Anti\u2013vascular endothelial growth factor resistance in exudative macular degeneration and polypoidal choroidal vasculopathy","volume":"3","author":"Kokame","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/bjophthalmol-2013-303444","article-title":"Polypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab response","volume":"98","author":"Hatz","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ajo.2009.02.012","article-title":"Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy","volume":"148","author":"Cho","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajo.2010.05.035","article-title":"Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab","volume":"150","author":"Stangos","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib5","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/IAE.0b013e3182695bf8","article-title":"Polypoidal choroidal vasculopathy\u2013An important diagnosis to make with therapeutic implications","volume":"32","author":"Kokame","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/ICU.0b013e3282fb7c33","article-title":"Polypoidal choroidal vasculopathy and treatments","volume":"19","author":"Gomi","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib9","first-page":"74","article-title":"Prospective evaluation of subretinal vessel location in polypoidal choroidal vasculopathy (PCV) and response of hemorrhagic and exudative PCV to high-dose antiangiogenic therapy (an American Ophthalmological Society Thesis)","volume":"112","author":"Kokame","year":"2014","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.oret.2021.05.009_bib10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/IAE.0b013e31823beb14","article-title":"Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings","volume":"32","author":"Khan","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib11","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jamaophthalmol.2020.2421","article-title":"Treatment for a subtype of exudative macular degeneration\u2014Another mountain climbed","volume":"138","author":"Kokame","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib12","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/IAE.0000000000002228","article-title":"Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography","volume":"39","author":"Cheung","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaophthalmol.2019.0565","article-title":"Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography of polypoidal choroidal vasculopathy","volume":"137","author":"Chaikitmongkol","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib14","article-title":"Polypoidal choroidal vasculopathy consensus nomenclature and non-indocyanine green angiographic diagnostic criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup","author":"Cheung","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.05.009_bib15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/IAE.0b013e318156db60","article-title":"Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy","volume":"28","author":"Saito","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/IAE.0000000000002139","article-title":"Sensitivity and specificity of detecting polypoidal choroidal vasculopathy with en face OCT and OCT angiography","volume":"39","author":"deCarlo","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2015.1886","article-title":"Polypoidal choroidal vasculopathy: imaging by indocyanine green angiography and en face optical coherence tomography","volume":"133","author":"Kokame","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjophthalmol-2013-304658","article-title":"En-face high penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy","volume":"99","author":"Sayanagi","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000481540","article-title":"Spectral domain optical coherence tomography angiography for the diagnosis and evaluation of polypoidal choroidal vasculopathy","volume":"239","author":"deCarlo","year":"2018","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2021.05.009_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjophthalmol-2016-309264","article-title":"Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy","volume":"101","author":"Tanaka","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib21","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Everest II Study Group. Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/IAE.0b013e3181a3b7d9","article-title":"Differences in macular morphology between polypoidal choroidal vasculopathy and exudative age-related macular degeneration detected by optical coherence tomography","volume":"29","author":"Ozawa","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.05.009_bib24","article-title":"Neovascular morphology by ICG angiography and response to loading-dose anti-VEGF therapy in patients with neovascular AMD: results of the PERSIST Study","volume":"57","author":"Mettu","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2021.05.009_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000439359","article-title":"Characteristics of neovascular age-related macular degeneration in Brazilian patients","volume":"234","author":"Pereira","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2021.05.009_bib26","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.05.009_bib27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","article-title":"Efficacy and safety of intravitreal aflibercept for polypoidal choroidal vasculoplasty in the PLANET study","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"16","key":"10.1016\/j.oret.2021.05.009_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12886-016-0305-2","article-title":"Prospective clinical trial of intravitreal aflibercept treatment for polypoidal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results","volume":"27","author":"Kokame","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.oret.2021.05.009_bib29","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","article-title":"Comparison of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: The EVEREST II randomized clinical trial","volume":"138","author":"Lim","year":"2020","journal-title":"JAMA Ophthalmol"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653021001688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653021001688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:29:39Z","timestamp":1762853379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653021001688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2468653021001688"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2021.05.009","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2021.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}